Truist Securities Maintains Hold on Medtronic, Raises Price Target to $87
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter has maintained a Hold rating on Medtronic (NYSE:MDT) and increased the price target from $84 to $87.

December 22, 2023 | 2:56 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities analyst Richard Newitter maintains a Hold rating on Medtronic but raises the price target from $84 to $87.
The increase in price target by Truist Securities suggests a slightly more optimistic outlook on Medtronic's valuation, which could be positive for the stock. However, since the rating remains a Hold, the impact is likely to be moderate as it does not indicate a strong buy or sell signal.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100